Female Infertility
Female Infertility is a hormonal condition involving difficulty achieving pregnancy. It is not itself a measure of fertilization, embryo quality, clinical pregnancy, or live birth; these are separate reproductive outcomes used to assess interventions in assisted reproductive technology (ART).
Female Infertility is categorized as a hormonal condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
3 options:2 some evidence1 not enough evidence
Mindfulness MeditationpracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
An RCT involving 100 people undergoing IVF-ET reported improved psychological outcomes, pain, and reproductive outcomes with mindfulness meditation versus conventional care. A separate RCT involving 34 women undergoing IVF also found improved psychosocial outcomes.
Open the Mindfulness Meditation pagePsychotherapypracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 4 studies with a clear result found a benefit.
A randomized trial in 120 couples with primary infertility after a failed assisted reproductive technique found improved negative sexual self-concept in both women and men receiving the intervention. A review also reported improvements in depressive symptoms, hopelessness and self-esteem after group psychodrama; anxiety improvement was not statistically significant.
Open the Psychotherapy pageMeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Open the Meditation page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition3 listedMost likely to help, from the evidence we have
- →PracticesMindfulness MeditationCertaintyMediumSourceClinical
An RCT involving 100 people undergoing IVF-ET reported improved psychological outcomes, pain, and reproductive outcomes with mindfulness meditation versus conventional care. A separate RCT involving 34 women undergoing IVF also found improved psychosocial outcomes.
Who was studied
- People with a condition
- Female Infertility
Open Mindfulness MeditationStudy result
MM group showed improved psychological outcomes, pain, and reproductive outcomes versus conventional care in infertile IVF-ET patients
- →PracticesPsychotherapyCertaintyMediumSourceClinical
A randomized trial in 120 couples with primary infertility after a failed assisted reproductive technique found improved negative sexual self-concept in both women and men receiving the intervention. A review also reported improvements in depressive symptoms, hopelessness and self-esteem after group psychodrama; anxiety improvement was not statistically significant.
Who was studied
- People with a condition
- Female Infertility
Open PsychotherapyStudy result
Significant pre-post improvements in depressive symptoms (BDI), hopelessness, and self-esteem in group psychodrama; anxiety improved but NS
Low probability(1)
- →PracticesMeditationCertaintyLowSourceClinical
RCT showing reduced distress and improved pregnancy rate
Open MeditationWho was studied
- People with a condition
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Female Infertility worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Female Infertility is a hormonal condition involving difficulty achieving pregnancy. It is not itself a measure of fertilization, embryo quality, clinical pregnancy, or live birth; these are separate reproductive outcomes used to assess interventions in assisted reproductive technology (ART). Findings summarized here come from specific study contexts, so they may not apply equally to every person or circumstance.
Evidence-backed options
Evidence for supplements associated with Female Infertility is concentrated in assisted reproductive technology (ART) outcomes rather than a single uniform population. Melatonin and Beetroot Extract are described in relation to ART, while Inositol is specifically discussed in poor ovarian responders. The health status of participants is otherwise not specified, so these findings may not apply equally to every person with Female Infertility.
Taken together, Coenzyme Q10 and Melatonin have the clearest support among the listed options, with findings involving clinical pregnancy and live birth for Coenzyme Q10 and fertilization, embryo quality, and clinical pregnancy for Melatonin. Beetroot Extract and Inositol have more limited support, while L-Carnitine is supported by a review describing possible effects on reproductive function rather than a specific clinical outcome. Evidence for an outcome during ART does not automatically establish improved fertility outside ART or a live birth.
The summarized findings do not specify what doses were used, how long options were taken, or how quickly effects appeared. They also do not establish that benefits are consistent across causes of infertility. A clinician can help interpret whether findings from ART or poor ovarian response research are relevant to an individual medical situation.